The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 45 sources its claims cite is checked for support yet.
Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age
Open accessAbstract
Temporally controlling Cre recombination through tamoxifen (Tam) induction has many advantages for biomedical research. Most studies report early post-natal/juvenile (<2 m.o.) Tam induction, but age-related neurodegeneration and aging studies can require Cre induction in older mice (>12 m.o.). While anecdotally reported as problematic, there are no published comparisons of Tam-mediated Cre induction at early and late ages. Here, microglial-specific Cx3cr1 creERT2 mice were crossed to a floxed NuTRAP reporter to compare Cre induction at early (3–6 m.o.) and late (20 m.o.) ages. Specificity and efficiency of microglial labeling at 21–22 m.o. were identical in mice induced with Tam at early and late ages. Age-related microglial translatomic changes were also similar regardless of Tam induction age. Each Cre and flox mouse line should be independently validated, however, these findings demonstrate that Tam-mediated Cre induction can be performed even into older mouse ages and should be generalizable to other inducible Cre models.
Checked 2026-11-19 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
In Cx3cr1creERT2;NuTRAP mice, tamoxifen-induced Cre labeling of microglia at 21–22 months was equally specific and efficient whether induced early (3–6 m.o.) or late (20 m.o.). Age-related microglial translatomic changes were also similar regardless of induction age.
Key findings
- At 21–22 m.o., ~20% of cortical singlets were eGFP+ in both early (n = 6, 4 females, 2 males) and late (n = 7, 5 females, 2 males) induction groups; >95% of eGFP+ cells were CD11b/CD45 double-positive (~98% in the figure legend). Efficiency was ~90% eGFP+ among CD11b+CD45mid cells and ~60% among CD11b+CD45high cells, with no difference by induction age.
- TRAP RNA-seq separated positive vs. input fractions in PCA component 1 (67.6% variance) but not by induction or collection age; microglial marker enrichment was equivalent across groups and correlated >0.97, while astrocyte, neuron, and oligodendrocyte markers were depleted.
- Differential expression with aging (old early n = 7, old late n = 5, young early n = 5; one-way ANOVA, Benjamini-Hochberg q < 0.1, fold change >|1.25|) was highly correlated between old early and old late induction groups. GSEA showed enrichment of DAM, ARM, MgND, and WAM subtypes and depletion of homeostatic microglia, plus senescence/SASP enrichment, similarly at both induction ages.
- Specific markers showed consistent age-related changes regardless of induction age: DAM markers increased, homeostatic markers decreased, senescence markers increased (p16Ink4a significantly, p19Arf less), and MHC-I genes B2m, H2-D1, H2-K1, H2-M3 and receptors Lilrb3, Lilrb4, Pilra increased.
Methods
- Cx3cr1creERT2 mice (Jax 020940) were crossed to floxed NuTRAP mice (Jax 029899). Tamoxifen was injected IP at 100 mg/kg daily for five consecutive days in sunflower seed oil at early (3–6 m.o.) or late (20 m.o.) age; brains were collected at 21–22 m.o. (and at 4 m.o. for young TRAP-seq).
- Cortex single-cell suspensions were analyzed by flow cytometry for CD11b/CD45/eGFP; hippocampal sections were immunostained for mCherry/CD11b/eGFP. Hippocampal TRAP isolation used anti-EGFP immunoprecipitation, followed by RNA-seq on an Illumina NovaSeq 6000.
- RNA-seq analysis used DESeq2 normalization, one-way ANOVA with Benjamini-Hochberg correction (q < 0.1) and fold change >|1.25|, GSEA, and Ingenuity Pathway Analysis. Main RNA-seq groups were young early induction (n = 5 females), old early induction (n = 7 females), and old late induction (n = 5 females); a smaller male set included young n = 4, old-early n = 5, old-late n = 2.
Limitations
- Stated: findings should be generalizable across Cre/ERT2 systems, but each Cre and floxed gene combination should be independently validated; mouse line-specific factors (e.g., cell type, size of flox construct) could alter results, and investigators should consider direct assessments of Cre recombination in addition to imaging, flow cytometry, and enrichment tests.
- Stated/evident: the main molecular findings were in female mice; the male analysis was smaller (young n = 4, old-early n = 5, old-late n = 2) and showed no/limited differences with age of induction.
- Evident: the late induction group had slightly higher fold changes, which the authors attribute to a possible batch effect driven by three samples collected together and to natural variability; no direct measurement of tamoxifen metabolites or half-life by age was performed in this study.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 18 Not checked · 42 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specificity and efficiency of microglial labeling at 21–22 m.o. were identical in mice induced with Tam at early and late ages.”
- Also stated in: § Microglial cell labeling specificity and efficiency are equivalent despite the age of cre induction · hedged
“Together, these data suggest that Tam induction of Cx3cr1-NuTRAP mice during early or late age results in similar cell specificity and efficiency of Cre recombination in microglia.”
- Also stated in: § Discussion · boosted
“Flow cytometry analysis of eGFP+ cells demonstrated high and equivalent levels of specificity and efficiency at both induction ages.”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Abstract
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Microglial cell labeling specificity and efficiency are equivalent despite the age of cre induction · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, there was depletion of marker genes for astrocytes, neurons, and oligodendrocytes in the positive fraction as compared to the input (Figures 3C and 3E; Tables S2 and S3).”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Age of cre induction does not alter TRAP isolation of microglial-specific RNA efficiency
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We observed increased expression of MHC-I genes B2m, H2-D1, H2-K1, and H2-M3, as well as MHC-I receptors, Lilrb3, Lilrb4, and Pilra (Figure 5D). These increases were seen in both induction ages to a similar degree”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Specific microglial responses with age are unaffected by age of Tam induction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“focusing on the most prominent (Figure 5A) DAM markers, there was consistent increase in old samples, regardless of induction age.”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Specific microglial responses with age are unaffected by age of Tam induction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Over 95% of eGFP+ cells were CD11b/CD45 double-positive, (Figure 1C)”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Microglial cell labeling specificity and efficiency are equivalent despite the age of cre induction
plainn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
24 more claims
Create a free account to see all 60 claims and to verify the 45 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 20
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Microglial cell labeling specificity and efficiency are equivalent despite the age of cre induction
“Single cell suspensions from aged (21–22 m.o.) cortex were collected from mice induced with Tam at either early (3–6 m.o., n = 6, 4 females, 2 males) or late (20 m.o., n = 7, 5 females, 2 males) age (Figure 1A)”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Microglial cell labeling specificity and efficiency are equivalent despite the age of cre induction
“(A) Experimental design of early Tam induction (4–6 m.o.) and late Tam induction (20 m.o.) in Cx3cr1-NuTRAP mice followed by brain collection for both groups at 21–22 m.o.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Specific microglial responses with age are unaffected by age of Tam induction
“p16Ink4a is more associated with senescence and demonstrated a significant increase, consistent between induction ages while p19Arf had smaller increases with age (Figure 5E).”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Specific microglial responses with age are unaffected by age of Tam induction
“(D) Boxplots showing the change with age in both groups of Cdkn2a and both of its isoforms, p19Arf and p16Ink4a.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Age of cre induction does not alter TRAP isolation of microglial-specific RNA efficiency
“there was no further separation by age of induction or age of collection (Figure 3B).”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > Results > Age of cre induction does not alter TRAP isolation of microglial-specific RNA efficiency
“(B) Translatome profiles separated in the first component between the Input and Positive fractions in the first component and to a degree between young and old mice in the 2nd component.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > STAR★Methods > Key resources table
“| Mouse: Cx3cr1-cre; NuTRAP: Cx3cr1Jung-cre/ERT2+/wt; NuTRAPflox/wt | Breeding at OMRF | N/A; Bred between 021160 and 029899 |”
§ Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age > STAR★Methods > Experimental model and study participant details
“Cx3cr1Jung-Cre/ERT2+/+ (stock #020940)22 males were mated with NuTRAPflox/flox females (stock # 029899)31 to generate the desired progeny, Cx3cr1Jung-cre/ERT2+/wt; NuTRAPflox/wt.32”
Citations
Cites
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Hammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225
Pleiotropy, natural selection, and the evolution of senescence
Williams, G. C. (1957) · Evolution · doi:10.2307/2406060 · Cited by 1,912
Cited by
Model systems to study tumor-microbiome interactions in early-onset colorectal cancer
Richter, K. M., Wrage, M., Krekeler, C., Oliveira, T. D., Conradi, L., Menck, K., & Bleckmann, A. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00198-3 · Cited by 13
Liu, J., Zaidi, A. H., & Pike, C. J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03534-z · Cited by 11
Looprasertkul, S., Yamazaki, R., Osanai, Y., & Ohno, N. (2025) · Glia · doi:10.1002/glia.70070 · Cited by 5
Need of orthogonal approaches in neurological disease modeling in mouse
Bossini, L., & Sessa, A. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1399953
Glutamine Metabolism Supports α cell Mass and Glucagon SecretionPreprint
Schornack, A. M. R., Rodgers, T. J., Shou, M., Siv, W., Yin, L., Sellick, K., Chigurupati, V., Debo, J., Saraf, S. S., Nickles, P. G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.09.735845
Metadata
- Authors
- Kellogg, C. M., Pham, K., Ko, S., Cox, J. E. J., Machalinski, A. H., Stout, M. B., Sharpe, A. L., Beckstead, M. J., Chucair-Elliott, A. J., Ocañas, S. R., & Freeman, W. M.
- Affiliations
- Oklahoma Medical Research Foundation (US)
- University of Oklahoma Health Sciences Center (US)
- Corresponding author
- Freeman, Willard M.
- ORCID
- Venue
- iScience
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 26
- Issue
- 12
- Pages
- 108413
- ISSN
- 2589-0042 (ISSN-L)
- PMC
- PMC10696116
- OpenAlex
- W4388534274
- Semantic Scholar
- 4e06f44483ff8eb888d9c933723c6d4a924b85cd
- Cited by
- 10
- References
- 72
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- iScience (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- PubMed (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute on Aging (F31AG064861, P30AG050911, R01AG059430, R21AG072811, T32AG052363)
- NIH Office of the Director (DP5OD033443, I01BX003906, I01BX005396, IK6BX006033)
- U.S. Department of Veterans Affairs
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- tamoxifen, Cre recombination, CreERT2, microglia, CX3CR1, aging, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age. https://app.cochat.ai/papers/10.1016/j.isci.2023.108413
- The paper
- Kellogg, C. M., Pham, K., Ko, S., Cox, J. E. J., Machalinski, A. H., Stout, M. B., Sharpe, A. L., Beckstead, M. J., Chucair-Elliott, A. J., Ocañas, S. R., & Freeman, W. M. (2023). Specificity and efficiency of tamoxifen-mediated Cre induction is equivalent regardless of age. iScience. https://doi.org/10.1016/j.isci.2023.108413
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.